SANTORO, Vincenza

SANTORO, Vincenza  

Dipartimento di Medicina Clinica e Sperimentale  

Mostra records
Risultati 1 - 20 di 22 (tempo di esecuzione: 0.042 secondi).
Titolo Data di pubblicazione Autore(i) File
6-MERS HYALURONAN OLIGOSACCHARIDES STIMULATE INFLAMMATORY RESPONSE IN NEURONAL-LIKE DIFFERENTIATED SH-SY5Y NEUROBLASTOMA CELLS 1-gen-2012 Scuruchi, M.; Avenoso, Angela; D'Ascola, Angela; Nastasi, G.; Campo, Salvatore Giuseppe; Santoro, Vincenza; Spina, Edoardo; Calatroni, Alberto; Campo, Giuseppe Maurizio
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 1-gen-2021 Barbieri, M. A.; Sorbara, E. E.; Cicala, G.; Santoro, V.; Cutroneo, P. M.; Franchina, T.; Spina, E.
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 1-gen-2021 Barbieri, Maria Antonietta; Cutroneo, Paola Maria; Baratelli, Chiara; Cicala, Giuseppe; Battaglia, Alessandro; Santoro, Vincenza; Andò, Giuseppe; Spina, Edoardo
ANTITHETIC ACTION OF HYALURONAN 6-MER IN UNDIFFERENTIATED AND DIFFERENTIATED SH-SY5Y CELLS 1-gen-2012 Scuruchi, M.; Avenoso, Angela; Santoro, Vincenza; D'Ascola, Angela; Nastasi, G.; Campo, Salvatore Giuseppe; Spina, Edoardo; Calatroni, Alberto; Campo, Giuseppe Maurizio
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 1-gen-2010 Muscatello, Maria Rosaria Anna; Micò, U; Pandolfo, Gianluca; Bruno, Antonio; Scimeca, G; Romeo, Vm; Santoro, Vincenza; Spina, Edoardo; Zoccali, Rocco Antonio
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 1-gen-2021 Minelli, A.; Barlati, S.; Vitali, E.; Bignotti, S.; Dattilo, V.; Tura, G. B.; Maffioletti, E.; Giacopuzzi, E.; Santoro, V.; Perusi, G.; Cobelli, C.; Magri, C.; Bonizzato, S.; Bocchio-Chiavetto, L.; Spina, E.; Vita, A.; Gennarelli, M.
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. 1-gen-2008 Spina, Edoardo; Santoro, Vincenza; Darrigo, C.
Drug dosage individualization based on a random-effects linear model 1-gen-2012 Diaz F.J.; Cogollo M.R.; Spina E.; Santoro V.; Rendon D.M.; de Leon J.
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olazapine and risperidone I patients with psychotic disorders 1-gen-2010 Santoro, Vincenza; D’Arrigo, C; Micò, U; Muscatello, Maria Rosaria Anna; Zoccali, Rocco Antonio; Spina, Edoardo
Effect of adjunctive duloxetine treatment on the plasma concentrations of clozapine, olanzapine and risperidone in patients with psychotic disorders 1-gen-2009 D’Arrigo, C; Santoro, Vincenza; Migliardi, G; Micò, U; Muscatello, Maria Rosaria Anna; Pandolfo, Gianluca; Spina, Edoardo
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 1-gen-2011 Muscatello, Maria Rosaria Anna; Bruno, Antonio; Pandolfo, Gianluca; Micò, U; Scimeca, G; DI NARDO, Floriana; Santoro, Vincenza; Spina, Edoardo; Zoccali, Rocco Antonio
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 1-gen-2011 Muscatello, Maria Rosaria Anna; Bruno, Antonio; Pandolfo, Gianluca; Micò, U; Scimeca, G; Romeo, VINCENZO MARIA; Santoro, Vincenza; Settineri, Salvatore; Spina, Edoardo; Zoccali, Rocco Antonio
Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders 1-gen-2007 Migliardi, G; D'Arrigo, C; Santoro, Vincenza; Bruno, Antonio; Cortese, L; Campolo, D; Cacciola, M; Spina, Edoardo
Effect of valproate on plasma concentrations of olanzapine in patients with psychotic disorders , July, 2009, MP 110.. 1-gen-2009 Spina, Edoardo; C., D’Arrigo; Santoro, Vincenza; Muscatello, Maria Rosaria Anna; Pandolfo, Gianluca; Zoccali, Rocco Antonio; F., Diaz; J., De Leon
Effetto di un trattamento con risperidone o olanzapina sui livelli serici di prolattina in bambini e adolescenti con patologie psichiatriche. 1-gen-2008 Migliardi, G; Darrigo, C; Santoro, Vincenza; Calarese, Tiziana; Gagliano, Antonella; Germano', Eva; Siracusano, Rosamaria; Spina, Edoardo
Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model. 1-gen-2008 Botts, S; Diaz, Fj; Santoro, Vincenza; Spina, Edoardo; Muscatello, Maria Rosaria Anna; Cogollo, M; Castro, Fe; DE LEON, J.
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 1-gen-2015 Italiano, Domenico; Bruno, Antonio; Santoro, Vincenza; Lanza, Giulia; Muscatello, Maria Rosaria Anna; Zoccali, Rocco Antonio; Spina, Edoardo
Interactions between antiepileptics and second generation antipsychotics 1-gen-2012 de Leon J; Santoro V; D'Arrigo C; Spina E.
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 1-gen-2017 Bruno, Antonio; Pandolfo, Gianluca; Crucitti, Manuela; Cacciola, Massimo; Santoro, Vincenza; Spina, Edoardo; Zoccali, Rocco Antonio; Muscatello, Maria Rosaria Anna
Pharmacokinetic interaction between duloxetine and second-generation antipsychotics in patients with psychotic disorders 1-gen-2010 Spina, Edoardo; D’Arrigo, C; Santoro, Vincenza; Micò, U; Muscatello, Maria Rosaria Anna; Pandolfo, Gianluca